151 related articles for article (PubMed ID: 26739552)
1. Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
Ahn HY; Chung YJ; Park KY; Cho BY
Thyroid; 2016 Mar; 26(3):429-33. PubMed ID: 26739552
[TBL] [Abstract][Full Text] [Related]
2. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.
Danilovic DL; Ferraz-de-Souza B; Fabri AW; Santana NO; Kulcsar MA; Cernea CR; Marui S; Hoff AO
PLoS One; 2016; 11(10):e0164550. PubMed ID: 27737011
[TBL] [Abstract][Full Text] [Related]
4. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Pre-Operative 25-Hydroxyvitamin D Levels and Poor Prognostic Factors for Papillary Thyroid Cancer.
Abuduwaili M; Xing Z; Xia B; Fei Y; Zhu J; Su A
J Invest Surg; 2022 May; 35(5):1076-1082. PubMed ID: 34865593
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
7. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
8. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
[TBL] [Abstract][Full Text] [Related]
9. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma.
Sulibhavi A; Rohlfing ML; Jalisi SM; McAneny DB; Doherty GM; Holick MF; Noordzij JP
Am J Otolaryngol; 2019; 40(4):536-541. PubMed ID: 31036419
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
12. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
[TBL] [Abstract][Full Text] [Related]
13. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
14. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
15. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
[TBL] [Abstract][Full Text] [Related]
16. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
17. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
[TBL] [Abstract][Full Text] [Related]
18. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
19. Severe vitamin D deficiency: a significant predictor of early hypocalcemia after total thyroidectomy.
Al-Khatib T; Althubaiti AM; Althubaiti A; Mosli HH; Alwasiah RO; Badawood LM
Otolaryngol Head Neck Surg; 2015 Mar; 152(3):424-31. PubMed ID: 25475499
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
